Supposedly, polysaccharides from edible mushrooms inhibit colitis, and polysaccharide extracts significantly inhibit the receptor-interacting protein kinase RIPK1–RIPK3–MLKL necroptotic signaling cascade, thereby decreasing the levels of phosphorylated MLKL in the mouse colon [106]. Here, RIPK3 is linked to colitis.